ARCHIVE

• Chuikyo to Start Discussions on Revision of NHI Price-setting Rules
  April 28, 2003

• OTC NEWS IN BRIEF
  April 28, 2003

• Only 1 Drug Received Premium for Innovation Since FY2002 Reform: HIB
  April 28, 2003

• BULLETIN
  April 28, 2003

• Committee Recommends Approval of Folinate/Tegafur/Uracil Therapy for Colorectal Cancer
  April 28, 2003

• MEDICAL DIVICE NEWS IN BRIEF
  April 28, 2003

• 18 New Products Including Arava, Capecitabine Receive Formal Approval
  April 28, 2003

• Japan's Makers Must Extricate Themselves from Out-licensing Patterns: FPMAJ President
  April 28, 2003

• Safety Measures for Cattle-derived Materials Strengthend
  April 28, 2003

• Mixing of Insurance-covered, Non-covered Care Difficult in Japan: Prof Ikegami
  April 28, 2003

• Pharmaceutical Industry Has Entered a Paradigm Shift: OPSR President
  April 28, 2003

• Nat'l Univ Hospitals Have to Report Serious Medical Accidents
  April 28, 2003

• REGULATORY NEWS IN BRIEF
  April 28, 2003

• Kaken Researchers Awarded JPSTJ Prize
  April 21, 2003

• No Conclusions Reached on Effects of Antioxidants on Cardiovascular Events: JCS Meeting
  April 21, 2003

• Only 13 GE Makers Can Supply Nationwide within 24 Hrs: EPMA Survey
  April 21, 2003

• Regenerative Medicine Promising for ALS, Spinal Injury: JHSF Report
  April 21, 2003

• Taiho Gathering Evidence on FU Anticancer Agent UFT
  April 21, 2003

• Aphoenix Explains Its Reverse Targeting Drug Discovery Technique
  April 21, 2003

• Integration of Kuraya Sanseido's Operations Going Smoothly: Ushioda Sangokudo
  April 21, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 602
• 603
• 604
• 605
• 606
• 607
• 608
• 609
• 610
• …
• Next ›
• 最終 »